Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, announced today that John A. Orwin, President and Chief Executive Officer, will present at the Cowen and Company 39th Annual Health Care Conference.
About Atreca, Inc.
Atreca is a privately held biotechnology company developing novel therapeutics based on a deep understanding of the human immune response. Atreca focuses in a unique way on the immune responses of patients in therapeutic areas where such responses are the key phenomenon driving clinical outcomes, enabling the Company to discover and develop novel immunotherapies. Atreca is advancing a pipeline of candidates designed to engage the human immune response in oncology and other indications, thus driving better therapeutic outcomes. For more information on Atreca, please visit www.atreca.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190304005102/en/
Contacts
Atreca, Inc.
Herb Cross
Chief Financial Officer
info@atreca.com
or
Media:
Nancie Steinberg, 212-213-0006, ext. 318
nsteinberg@burnsmc.com
Robert Flamm, 212-213-0006, ext. 364
rflamm@burnsmc.com
or
Investors:
Alex Gray, 212-213-0006, ext. 355
agray@burnsmc.com
Source: Atreca, Inc.
View this news release online at:
http://www.businesswire.com/news/home/20190304005102/en
